BIGT vs. UKRE ETF Comparison

Comparison of L&G Pharma Breakthrough UCITS ETF (BIGT) to iShares MSCI Target UK Real Estate UCITS ETF (UKRE)
BIGT

L&G Pharma Breakthrough UCITS ETF

BIGT Description

The objective of the fund is to provide exposure to a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. The Index selects stocks that meet certain size and liquidity requirements using a two-fold approach that is primarily based on the trend in the valuation of a company’s orphan drug portfolio and its overall revenue forecasts.

Grade (RS Rating)

Last Trade

£727.45

Average Daily Volume

2,823

Number of Holdings *

8

* may have additional holdings in another (foreign) market
UKRE

iShares MSCI Target UK Real Estate UCITS ETF

UKRE Description The Fund aims to achieve a return on your investment, through a combination of capital growth and income on the Fund¡¯s assets, which reflects the return of the MSCI UK IMI Liquid Real Estate Index, the Fund¡¯s benchmark index (Index).

Grade (RS Rating)

Last Trade

£396.80

Average Daily Volume

64,504

Number of Holdings *

29

* may have additional holdings in another (foreign) market
Performance
Period BIGT UKRE
30 Days -5.88% -1.35%
60 Days -6.52% -1.50%
90 Days -8.45% -0.41%
12 Months -22.58% -4.61%
0 Overlapping Holdings
Symbol Grade Weight in BIGT Weight in UKRE Overlap
BIGT Overweight 8 Positions Relative to UKRE
Symbol Grade Weight
0MH6 C 2.61%
0DPB F 2.37%
0L35 B 2.37%
0QLR F 2.27%
0QZU D 2.27%
0R1B F 2.26%
0RQE D 2.23%
0RC6 F 2.19%
BIGT Underweight 29 Positions Relative to UKRE
Symbol Grade Weight
SGRO D -10.91%
LMP B -5.59%
LAND D -4.87%
UTG D -3.72%
BLND B -3.39%
BBOX D -3.11%
GRI D -2.47%
BYG B -2.43%
DLN C -2.34%
PHP F -2.12%
AGR F -1.95%
SAFE D -1.66%
SRE B -1.03%
SUPR F -1.02%
ESP D -0.91%
GPE B -0.85%
CREI C -0.69%
IWG D -0.69%
THRL D -0.68%
IHR C -0.68%
UKCM C -0.63%
WKP F -0.52%
SHED F -0.52%
BCPT B -0.49%
PRSR D -0.46%
PCTN C -0.45%
HMSO A -0.33%
WHR F -0.31%
CLI F -0.12%
Compare ETFs